Literature DB >> 19402216

Aberrant pyramidal tract in medial lemniscus of brainstem in the human brain.

Ji Heon Hong1, Su Min Son, Woo Mok Byun, Han Won Jang, Sang Ho Ahn, Sung Ho Jang.   

Abstract

The aberrant pyramidal tract (APT) refers to the collateral pathway of the pyramidal tract through the medial lemniscus in the brainstem. We showed the presence of an APT in the normal human brain using diffusion tensor tractography. Diffusion tensor tractography showed that the motor tracts of the 28 hemispheres in 14 healthy normal individuals originated from the primary sensori-motor cortex and descended through the known pathway of the pyramidal tract. However, in five (17.9%) of the 28 hemispheres, we observed that the APT descended through the medial lemniscus from the midbrain to the pons, and then entered into the pyramidal tract at the upper medulla, after which it descended through the pyramidal tract to the lower medulla.

Entities:  

Mesh:

Year:  2009        PMID: 19402216     DOI: 10.1097/wnr.0b013e32832a5c86

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Characteristics of the aberrant pyramidal tract in comparison with the pyramidal tract in the human brain.

Authors:  Hyeok Gyu Kwon; Su Min Son; Min Cheol Chang; Saeyoon Kim; Yong Hyun Kwon; Sung Ho Jang
Journal:  BMC Neurosci       Date:  2011-11-01       Impact factor: 3.288

Review 2.  Aberrant Pyramidal Tract in Comparison with Pyramidal Tract on Diffusion Tensor Tractography: A Mini-Review.

Authors:  Sungho Jang; Soyoung Kwak
Journal:  Front Neurol       Date:  2017-06-28       Impact factor: 4.003

Review 3.  Brain connectivity plasticity in the motor network after ischemic stroke.

Authors:  Lin Jiang; Huijuan Xu; Chunshui Yu
Journal:  Neural Plast       Date:  2013-04-24       Impact factor: 3.599

4.  Motor recovery via aberrant pyramidal tract in a patient with traumatic brain injury: A diffusion tensor tractography study.

Authors:  Sang Seok Yeo; Sung Ho Jang
Journal:  Neural Regen Res       Date:  2013-01-05       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.